Company Filing History:
Years Active: 2014
Title: Virajkumar B Ghandi: Innovator in Kinase Inhibition
Introduction
Virajkumar B Ghandi is a notable inventor based in Gurnee, IL (US). He has made significant contributions to the field of pharmaceutical sciences, particularly in the development of kinase inhibitors. His work is crucial in the ongoing fight against diseases such as cancer.
Latest Patents
Ghandi holds a patent for Pyridazino[4,5-D]pyrimidin-5(6H)-one inhibitors of kinases. This invention relates to compounds of formula (I) or pharmaceutical acceptable salts, wherein B, R, R, R, and m are defined in the description. The patent also covers compositions containing these compounds, which are useful for inhibiting kinases such as wee-1. This innovation has potential applications in treating various diseases, including cancer.
Career Highlights
Virajkumar B Ghandi is currently employed at AbbVie Inc., a leading global biopharmaceutical company. His work at AbbVie focuses on developing innovative therapies that address unmet medical needs. Ghandi's expertise in kinase inhibitors positions him as a valuable asset in the pharmaceutical industry.
Collaborations
Ghandi has collaborated with esteemed colleagues such as Gui-Dong Zhu and Jane Gong. These partnerships enhance the research and development efforts at AbbVie, fostering an environment of innovation and discovery.
Conclusion
Virajkumar B Ghandi is a prominent inventor whose work in kinase inhibition is paving the way for new cancer treatments. His contributions to the field are significant and reflect his commitment to advancing medical science.